Boai NKY Medical Holdings Ltd. (300109.SZ)
CNY 17.2
(6.57%)
CNY 17.2
(6.57%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 4.01 Billion CNY | 8.24% |
| 2022 | 3.71 Billion CNY | -6.93% |
| 2021 | 3.98 Billion CNY | -3.75% |
| 2020 | 4.14 Billion CNY | -1.22% |
| 2019 | 4.19 Billion CNY | 82.22% |
| 2018 | 2.3 Billion CNY | 17.59% |
| 2017 | 1.95 Billion CNY | 49.53% |
| 2016 | 1.3 Billion CNY | 5.98% |
| 2015 | 1.23 Billion CNY | 160.41% |
| 2014 | 474.62 Million CNY | 12.3% |
| 2013 | 422.64 Million CNY | 3.18% |
| 2012 | 409.62 Million CNY | 5.1% |
| 2011 | 389.73 Million CNY | 8.92% |
| 2010 | 357.81 Million CNY | 222.93% |
| 2009 | 110.8 Million CNY | 21.15% |
| 2008 | 91.45 Million CNY | 37.19% |
| 2007 | 66.66 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q3 | 4.3 Billion CNY | -2.42% |
| 2024 Q1 | 4.1 Billion CNY | 2.24% |
| 2024 Q2 | 4.41 Billion CNY | 7.33% |
| 2023 Q2 | 3.74 Billion CNY | -1.4% |
| 2023 Q4 | 4.01 Billion CNY | 1.23% |
| 2023 Q1 | 3.79 Billion CNY | 2.15% |
| 2023 FY | 4.01 Billion CNY | 8.24% |
| 2023 Q3 | 3.97 Billion CNY | 6.16% |
| 2022 Q4 | 3.71 Billion CNY | -2.76% |
| 2022 Q3 | 3.81 Billion CNY | 2.22% |
| 2022 Q1 | 3.8 Billion CNY | -4.65% |
| 2022 Q2 | 3.73 Billion CNY | -1.8% |
| 2022 FY | 3.71 Billion CNY | -6.93% |
| 2021 Q2 | 4.36 Billion CNY | 2.76% |
| 2021 FY | 3.98 Billion CNY | -3.75% |
| 2021 Q1 | 4.24 Billion CNY | 2.35% |
| 2021 Q3 | 4.37 Billion CNY | 0.3% |
| 2021 Q4 | 3.98 Billion CNY | -8.76% |
| 2020 FY | 4.14 Billion CNY | -1.22% |
| 2020 Q3 | 4.13 Billion CNY | -1.84% |
| 2020 Q2 | 4.21 Billion CNY | 0.24% |
| 2020 Q1 | 4.2 Billion CNY | 0.26% |
| 2020 Q4 | 4.14 Billion CNY | 0.14% |
| 2019 Q2 | 4.04 Billion CNY | 72.51% |
| 2019 Q4 | 4.19 Billion CNY | 2.47% |
| 2019 FY | 4.19 Billion CNY | 82.22% |
| 2019 Q1 | 2.34 Billion CNY | 1.78% |
| 2019 Q3 | 4.09 Billion CNY | 1.28% |
| 2018 Q4 | 2.3 Billion CNY | 6.51% |
| 2018 FY | 2.3 Billion CNY | 17.59% |
| 2018 Q3 | 2.16 Billion CNY | 4.39% |
| 2018 Q1 | 2 Billion CNY | 2.51% |
| 2018 Q2 | 2.07 Billion CNY | 3.16% |
| 2017 Q3 | 1.56 Billion CNY | 14.12% |
| 2017 Q1 | 1.34 Billion CNY | 2.88% |
| 2017 Q2 | 1.37 Billion CNY | 1.67% |
| 2017 FY | 1.95 Billion CNY | 49.53% |
| 2017 Q4 | 1.95 Billion CNY | 25.27% |
| 2016 Q3 | 1.29 Billion CNY | -16.84% |
| 2016 Q2 | 1.56 Billion CNY | 0.04% |
| 2016 Q4 | 1.3 Billion CNY | 0.92% |
| 2016 FY | 1.3 Billion CNY | 5.98% |
| 2016 Q1 | 1.56 Billion CNY | 26.23% |
| 2015 Q1 | 485 Million CNY | 2.19% |
| 2015 FY | 1.23 Billion CNY | 160.41% |
| 2015 Q2 | 478.93 Million CNY | -1.25% |
| 2015 Q3 | 1.22 Billion CNY | 156.64% |
| 2015 Q4 | 1.23 Billion CNY | 0.55% |
| 2014 Q2 | 432.64 Million CNY | 1.43% |
| 2014 FY | 474.62 Million CNY | 12.3% |
| 2014 Q4 | 474.62 Million CNY | 5.85% |
| 2014 Q3 | 448.41 Million CNY | 3.64% |
| 2014 Q1 | 426.53 Million CNY | 0.92% |
| 2013 Q3 | 401.09 Million CNY | 1.59% |
| 2013 Q1 | 404.75 Million CNY | -1.19% |
| 2013 FY | 422.64 Million CNY | 3.18% |
| 2013 Q4 | 422.64 Million CNY | 5.37% |
| 2013 Q2 | 394.81 Million CNY | -2.46% |
| 2012 Q2 | 385.95 Million CNY | -2.77% |
| 2012 FY | 409.62 Million CNY | 5.1% |
| 2012 Q1 | 396.94 Million CNY | 1.85% |
| 2012 Q4 | 409.62 Million CNY | 2.61% |
| 2012 Q3 | 399.2 Million CNY | 3.43% |
| 2011 Q2 | 370.25 Million CNY | 1.86% |
| 2011 Q3 | 396.01 Million CNY | 6.96% |
| 2011 FY | 389.73 Million CNY | 8.92% |
| 2011 Q4 | 389.73 Million CNY | -1.59% |
| 2011 Q1 | 363.5 Million CNY | 1.59% |
| 2010 Q3 | 355.18 Million CNY | 203.32% |
| 2010 Q2 | 117.1 Million CNY | 0.68% |
| 2010 FY | 357.81 Million CNY | 222.93% |
| 2010 Q4 | 357.81 Million CNY | 0.74% |
| 2010 Q1 | 116.31 Million CNY | 4.97% |
| 2009 Q4 | 110.8 Million CNY | 0.0% |
| 2009 FY | 110.8 Million CNY | 21.15% |
| 2008 FY | 91.45 Million CNY | 37.19% |
| 2007 FY | 66.66 Million CNY | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Zhejiang Int'l Group Co.,Ltd. | 13.9 Billion CNY | 71.1% |
| Zhejiang Zhenyuan Share Co., Ltd. | 2.98 Billion CNY | -34.699% |
| Hunan Jingfeng Pharmaceutical Co.,Ltd. | 1.06 Billion CNY | -279.092% |
| Hubei Guangji Pharmaceutical Co., Ltd. | 3.02 Billion CNY | -32.684% |
| Yifan Pharmaceutical Co., Ltd. | 11.49 Billion CNY | 65.045% |
| Guangdong Jiaying Pharmaceutical Co., Ltd | 847.56 Million CNY | -374.265% |
| Sichuan Kelun Pharmaceutical Co., Ltd. | 36.52 Billion CNY | 88.995% |
| Chongqing Lummy Pharmaceutical Co., Ltd. | 2.89 Billion CNY | -39.047% |
| Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. | 2.56 Billion CNY | -56.886% |